Pharmaceutical Industry Articles & Reports - Page 20

Learn how OpenAI Codex assists biotech research by automating bioinformatics tasks. Read our analysis of its technical capabilities, use cases, and limitations.

Review regulatory requirements for assembling pharma AI validation evidence packages. Examine FDA and EMA guidelines, credibility frameworks, and GxP rules.

Review how Large Language Models (LLMs) extract adverse drug events from clinical notes. Learn about NLP model accuracy, implementation, and performance metrics

Analyze the FDA CDER 2026 guidance pipeline for artificial intelligence in drug manufacturing and digital health technologies in pharmaceutical development.

An educational analysis of the IQVIA.ai platform, detailing how NVIDIA-powered agentic AI orchestrates pharmaceutical operations and clinical trial workflows.

Explore how pharmaceutical companies use low-code platforms to build GxP-compliant MES and QMS applications while meeting strict 21 CFR Part 11 standards.

Examine the role of agentic AI in pharmaceutical commercial launches. Learn how autonomous multi-agent systems optimize market access and HCP engagement.

Explore how to structure a Pharma AI Center of Excellence. This guide covers organizational design, hub-and-spoke models, AI governance, and enterprise scaling.

Learn how AI-powered pharma smart factories enable autonomous GMP manufacturing, real-time quality control, and continuous production using digital twins.

Explore SAP S/4HANA implementation in pharmaceutical manufacturing. This guide details GxP compliance, module selection, and computer system validation.

Examine 2026 AI infrastructure investments in pharmaceutical R&D. This report details the Lilly-NVIDIA lab, Earendil funding, and GPU compute deployments.

Examine how pharma organizations deploy private LLMs using air-gapped AI architecture to maintain data sovereignty and comply with FDA and GDPR regulations.

This 2026 guide analyzes GxP compliance software, offering a detailed comparison of eQMS platforms, regulatory standards, and life science quality management.

Examine the 2026 landscape of AI biologics discovery. This analysis details protein modeling, generative design, and key pharma R&D investment trends.

Analyze AI robotics applications in pharma GMP manufacturing. This report details automation use cases across R&D, aseptic fill-finish, packaging, and ROI data.

Read this guide on evaluating digital quality systems (eQMS) for CDMOs. Learn about contract manufacturing software selection, GMP compliance, and integration.

Analyze leading GxP compliance software, eQMS, and document management platforms for life sciences. Learn how systems meet 21 CFR Part 11 and ALCOA+ rules.

Compare ELN, LIMS, and SDMS for pharmaceutical labs. This 2026 guide explains architectural differences, features, compliance, and specific R&D use cases.

Learn how pharma companies build regulatory-grade real-world evidence (RWE) platforms using real-world data for FDA and EMA drug development submissions.

An overview of molecular pathology software, examining LIMS for NGS workflows, multi-omics data integration, and AI analysis tools in precision medicine.

Examine the integration of AI in pharmaceutical CMC submissions and process analytics. Review QbD frameworks, regulatory guidelines, and manufacturing outcomes.

Review NIS2 Directive requirements for the pharma industry. This 2026 cybersecurity compliance checklist covers IT/OT, supply chain, and incident reporting.

Analyze the impact of 2026 U.S. pharma tariffs on global drug supply chains, manufacturing onshoring investments, and digital IT strategy for compliance.

A comprehensive comparison of RTSM software and IRT platforms for clinical trials. Analyze randomization features, trial supply management, and vendor options.